blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3127916

EP3127916 - ISOLATION OF PLASMA OR SERUM PROTEINS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  30.04.2021
Database last updated on 07.10.2024
FormerExamination is in progress
Status updated on  01.09.2017
FormerRequest for examination was made
Status updated on  11.08.2017
FormerThe application has been published
Status updated on  06.01.2017
Most recent event   Tooltip30.04.2021Refusal of applicationpublished on 02.06.2021  [2021/22]
Applicant(s)For all designated states
Evolve Biologics Inc.
420 Ambassador Drive
Mississauga, ON L5T 2J3 / CA
[2020/52]
Former [2017/06]For all designated states
Therapure Biopharma Inc.
2585 Meadowpine Blvd
Mississauga ON L5N 8H9 / CA
Inventor(s)01 / LIHME, Allan Otto Fog
Furesöbakken 13
DK-3460 Birkeröd / DK
 [2017/06]
Representative(s)Beck Greener LLP
Fulwood House
12 Fulwood Place
London WC1V 6HR / GB
[N/P]
Former [2017/06]Beck Greener
Fulwood House
12 Fulwood Place
London WC1V 6HR / GB
Application number, filing date16190233.307.06.2005
[2017/06]
Priority number, dateDK2004000089107.06.2004         Original published format: DK 200400891
DK2004000106205.07.2004         Original published format: DK 200401062
[2017/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3127916
Date:08.02.2017
Language:EN
[2017/06]
Search report(s)(Supplementary) European search report - dispatched on:EP15.11.2016
ClassificationIPC:C07K14/81, C07K14/76, C07K14/75, C07K14/755, C07K14/47, C07K1/16, B01D15/08, B01D15/20, B01D15/42
[2017/06]
CPC:
B01D15/08 (EP,US); B01D15/206 (EP,US); B01D15/424 (EP,US);
C07K1/16 (EP,US); C07K14/47 (EP,US); C07K14/75 (EP,US);
C07K14/755 (EP,US); C07K14/76 (EP,US); C07K14/79 (US);
C07K14/81 (EP,US); C07K16/00 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/37]
Former [2017/06]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ISOLIERUNG VON PLASMA- ODER SERUMPROTEINEN[2017/06]
English:ISOLATION OF PLASMA OR SERUM PROTEINS[2017/06]
French:ISOLATION DE PROTÉINES SÉRIQUES OU PLASMATIQUES[2017/06]
Examination procedure22.09.2016Date on which the examining division has become responsible
07.08.2017Amendment by applicant (claims and/or description)
07.08.2017Examination requested  [2017/37]
04.09.2017Despatch of a communication from the examining division (Time limit: M06)
12.03.2018Reply to a communication from the examining division
26.03.2018Despatch of a communication from the examining division (Time limit: M02)
23.05.2018Reply to a communication from the examining division
19.06.2018Despatch of a communication from the examining division (Time limit: M02)
08.08.2018Reply to a communication from the examining division
07.01.2019Despatch of a communication from the examining division (Time limit: M04)
15.05.2019Reply to a communication from the examining division
22.12.2020Cancellation of oral proceeding that was planned for 26.01.2021
18.01.2021Despatch of communication that the application is refused, reason: substantive examination [2021/22]
26.01.2021Date of oral proceedings (cancelled)
28.01.2021Application refused, date of legal effect [2021/22]
Parent application(s)   TooltipEP05746285.5  / EP1765866
EP10184552.7  / EP2277912
Fees paidRenewal fee
22.09.2016Renewal fee patent year 03
22.09.2016Renewal fee patent year 04
22.09.2016Renewal fee patent year 05
22.09.2016Renewal fee patent year 06
22.09.2016Renewal fee patent year 07
22.09.2016Renewal fee patent year 08
22.09.2016Renewal fee patent year 09
22.09.2016Renewal fee patent year 10
22.09.2016Renewal fee patent year 11
22.09.2016Renewal fee patent year 12
29.06.2017Renewal fee patent year 13
28.06.2018Renewal fee patent year 14
19.06.2019Renewal fee patent year 15
30.06.2020Renewal fee patent year 16
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US4416783  (NOGUCHI KOHJI [JP], et al) [A] 1-14 * columns 3,10; example 3; claim 18 *;
 [A]WO9717132  (PHARMACIA BIOTECH AB [SE], et al) [A] 1-14 * page 7; claims 1-8 *;
 [Y]WO9961475  (OCTAPHARMA AG [CH], et al) [Y] 1-14 * page 3 - page 5; example 1; claims 1-14 *;
 [Y]WO9965586  (UPFRONT CHROMATOGRAPHY AS [DK], et al) [Y] 1-14 * page 11 - page 13; examples 1-4 *;
 [A]US2002104801  (VOUTE NICOLAS [FR], et al) [A] 1-14 * example 23; claims 6,23-28 *;
 [Y]WO02096215  (UPFRONT CHROMATOGRAPHY AS [DK], et al) [Y] 1-14 * page 12 - page 22; figures 1,3,9; claims 1,19,20 *;
 [XP]WO2004082397  (UPFRONT CHROMATOGRAPHY AS [DK], et al) [XP] 1-3,8,14 * examples 1-13; claims 1,9-12 *;
 [Y]  - BURNOUF T, "Chromatography in plasma fractionation: benefits and future trends", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES AND APPLICATIONS, ELSEVIER SCIENCE PUBLISHERS, NL, (19950203), vol. 664, no. 1, doi:10.1016/0378-4347(94)00532-A, ISSN 0378-4347, pages 3 - 15, XP004043701 [Y] 1-14 * abstract * * page 13 *

DOI:   http://dx.doi.org/10.1016/0378-4347(94)00532-A
 [A]  - KARAU A ET AL., "Influence of particle size distribution and operating conditions on the adsorption performance in fluidized beds", BIOTECHNOLOGY AND BIOENGINEERING, (19970705), vol. 55, no. 1, ISSN 0006-3592, pages 54 - 64, XP002345865 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1002/(SICI)1097-0290(19970705)55:1<54::AID-BIT7>3.0.CO;2-W
 [A]  - AKINORI S ET AL., "Purification of recombinant human serum albumin. Efficient purification using STREAMLINE", BIOSEPARATION, (1999), vol. 8, no. 1, ISSN 0923-179X, pages 195 - 200, XP002345866 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1023/A:1008081314112
 [T]  - LIHME A ET AL, "A novel core fractionation process of human plasma by expanded bed adsorption chromatography", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS INC, NEW YORK, vol. 399, no. 1, doi:10.1016/J.AB.2009.12.002, ISSN 0003-2697, (20100401), pages 102 - 109, (20091206), XP026896792 [T] * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ab.2009.12.002
by applicantUS2390074
 US2469193
 US4481189
 WO9200799
 WO9216292
 WO9218237
 EP0722771
 WO9951316
 WO9965586
 US6036861
 WO0025884
 WO0057982
 WO0185329
 WO0205923
 US6610630
 US6617133
    - FINETTE G.M.S ET AL., BIOTECHNOL. PROG., (1998), vol. 14, pages 286 - 293
    - COHN ET AL., "Separation into Fractions of Protein and Lipoprotein Components", J. AM. CHEM. SOC, (1946), vol. 68, pages 459 - 475
    - E, 3. COHN ET AL., "Preparation and Properties of Serum and Plasma Proteins, IV, A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids", THE JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (194601), vol. LXVIII, pages 459 - 475
    - E. J. COHN ET AL., "Preparation and Properties of Serum and Plasma Proteins, IV, A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids", THE JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (194601), vol. LXVIII, pages 459 - 475
    - SCAND. J. IMMUNOL., (1983), vol. 17, no. 10, pages 41 - 56
    - SCAND. J. IMMUNOL, (1983), vol. 17, no. 10, pages 41 - 56
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.